HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adenosine 5'-triphosphate (ATP) inhibits schwann cell demyelination during Wallerian degeneration.

Abstract
Adenosine 5'-triphosphate (ATP) is implicated in intercellular communication as a neurotransmitter in the peripheral nervous system. In addition, ATP is known as lysosomal exocytosis activator. In this study, we investigated the role of extracellular ATP on demyelination during Wallerian degeneration (WD) using ex vivo and in vivo nerve degeneration models. We found that extracellular ATP inhibited myelin fragmentation and axonal degradation during WD. Furthermore, metformin and chlorpromazine, lysosomal exocytosis antagonists blocked the effect of ATP on the inhibition of demyelination. Thus, these findings indicate that ATP-induced-lysosomal exocytosis may be involved in demyelination during WD.
AuthorsYoun Ho Shin, Hyung-Joo Chung, Chan Park, Junyang Jung, Na Young Jeong
JournalCellular and molecular neurobiology (Cell Mol Neurobiol) Vol. 34 Issue 3 Pg. 361-8 (Apr 2014) ISSN: 1573-6830 [Electronic] United States
PMID24363123 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adenosine Triphosphate
Topics
  • Adenosine Triphosphate (pharmacology, therapeutic use)
  • Animals
  • Cells, Cultured
  • Demyelinating Diseases (pathology, prevention & control)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Organ Culture Techniques
  • Schwann Cells (drug effects, pathology)
  • Wallerian Degeneration (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: